Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1
In conclusion, IMP significantly inhibits the progression of PCa, offering new insights into potential treatments for CRPC.
Authors
- Jing Lv
- Yuwei Zhang (ORCID: https://orcid.org/0000-0003-1337-1081)
- Shengkai Jin
- Yichen Lu (ORCID: https://orcid.org/0000-0003-0296-3540)
- Yuhua Zhou (ORCID: https://orcid.org/0009-0005-4490-804X)
- Ninghan Feng
- Menglu Li
Institutions
- Jiangnan University (CN)
- Nantong University (CN)
- Wuxi No.2 People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Molecular Medicine
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1186/s10020-025-01073-0
- Citations
- 1
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Jiangsu Commission of Health
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Wuxi Municipal Bureau on Science and Technology